title: Nonsurgical therapy for stages I and II non-small cell lung cancer.
abstract: For patients who have stages I and II non-small cell lung cancer (NSCLC) and who are unable or unwilling to undergo surgical resection, nonsurgical treatment modalities have been used with curative intent. Conventionally fractionated radiotherapy has been the mainstay of nonsurgical therapy; however, advances in technology and the clinical application of radiobiologic principles have allowed more accurately targeted treatment that delivers higher effective doses to the tumor, while respecting the tolerance of surrounding normal tissues. This article discusses nonsurgical approaches to the treatment of early-stage NSCLC, including several promising techniques, such as radiation dose escalation, altered radiation fractionation, stereotactic radiotherapy, and radiofrequency ablation.
authors.affiliation: Department of Radiation Oncology, Stanford Cancer Center, 875 Blake Wilbur Drive, MC 5847, Stanford University, Stanford, CA 94305-5847, USA. qle@stanford.edu
authors.forename: Quynh-Thu
authors.initials: QT
authors.lastname: Le
authors.forename: David W
authors.initials: DW
authors.lastname: Petrik
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology / Q000532:radiotherapy*; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D009367:Neoplasm Staging; D018714:Radiotherapy, Adjuvant